A fast and simple method for preparation of calcium carbonate–drug composites for fast drug release
Source abstract
Abstract
Abstract Novel ways to synthesize CaCO 3 based matrices to increase the dissolution rate of naproxen are investigated. The composites were prepared using 3 methods, all starting from aqueous solutions of CaCl 2 ·6H 2 O and NaHCO 3 , while the differences were in how the solutions were mixed and dried. The fast disintegration of the matrix from the composites was explained by swift dispersion of the matrix into tiny drug particles, thus allowing for their fast dissolution. Modifications in the preparation procedures resulted in formation of different portions of CaCO 3 crystal forms. Despite the identical drug composition, dissolution of naproxen from the composites was considerably faster than the dissolution of pure naproxen. The dissolution was the fastest in the samples containing the highest amount of the less stable CaCO 3 crystal form, vaterite. The proposed composite formulation could be interesting for per os applications where fast attainment of high blood concentration and its preservation is required.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Drug Solubulity and Delivery Systems · Calcium Carbonate Crystallization and Inhibition · Polymer Surface Interaction Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (27)
Show source-provided references
1. Griffin · 2009
2. Deo · Anal. Chem. · 2003 · 75 · 206A10.1021/ac0313217 ↗
3. Kortesuo · J. Biomed. Mater. Res. · 1999 · 44 · 16210.1002/(SICI)1097-4636(199902)44:2<162::AID-JBM6>3.0.CO;2-P ↗
4. Madbouly · 2010
5. Emileh · Eur. Polym. J. · 2007 · 43 · 198610.1016/j.eurpolymj.2007.02.002 ↗
6. Marentette · J. Pharm. Sci. · 1992 · 81 · 31810.1002/jps.2600810403 ↗
7. Zahedi · Eur. J. Pharm. Biopharm. · 2007 · 65 · 32010.1016/j.ejpb.2006.10.025 ↗
8. Mura · J. Pharmaceut. Biomed. · 2002 · 29 · 101510.1016/S0731-7085(02)00142-5 ↗
9. Bogdanova · Pharmaceut. Res. · 2005 · 22 · 80610.1007/s11095-005-2598-3 ↗
10. Miller-Chou · Prog. Polym. Sci. · 2003 · 28 · 122310.1016/S0079-6700(03)00045-5 ↗
11. Chiou · J. Pharm. Sci. · 1971 · 60 · 128110.1002/jps.2600600902 ↗
12. Bettinetti · Drug Dev. Ind. Pharm. · 1994 · 20 · 135310.3109/03639049409038375 ↗
13. Fausett · AAPS PharmSciTech. · 2000 · 1 · E2010.1208/pt010320 ↗
14. Eichman · Pharmaceut. Res. · 1998 · 15 · 92510.1023/A:1011936901638 ↗
15. A.M. Schobel, U.S. Patent 4,687,662 (1987).
16. Bettinetti · Eur. J. Pharm. Sci. · 2002 · 15 · 2110.1016/S0928-0987(01)00199-3 ↗
17. Tungprapa · Polymer · 2007 · 48 · 503010.1016/j.polymer.2007.06.061 ↗
18. Mura · Eur. J. Pharm. Sci. · 2003 · 19 · 6710.1016/S0928-0987(03)00068-X ↗
19. The United States Pharmacopoeia, United States Phamacopeial Convention Inc., Rockville, 2005.
20. Robinson · 1968
21. European pharmacopoeia · 2010
22. del Arco · J. Solid State Chem. · 2004 · 177 · 395410.1016/j.jssc.2004.08.006 ↗
23. The MERCK Index 13th ed., Merck & Company Incorporated, Whitehouse Station, New Jersey, 2001.
24. Villain · Cem. Concr. Res. · 2007 · 37 · 118210.1016/j.cemconres.2007.04.015 ↗
25. R.W. Baker, H.S. Lonsdale, Plenum Press, New York, NY, 1974, pp. 15–71.10.1007/978-1-4684-7239-4_2 ↗
26. Korsmayer · Int. J. Pharm. · 1983 · 15 · 2510.1016/0378-5173(83)90064-9 ↗
27. Kim · J. Pharm. Sci. · 1997 · 86 · 32310.1021/js960307p ↗